May 09, 2018: New US Patent Granted for a Supramolecular Smart Drug Delivery System with Water-Soluble Supramolecular Complexes.

March 14, 2017: New US Patent Granted for a Supramolecular Smart Drug Delivery Technology.

September 10, 2016: Broda Technologies Co., Ltd. today announced it has been granted Japanese Patent Registration No. 5980304 on August 5, 2016 for a patent titled “Reversely Thermal-Reversible Hydrogel Compositions”.

June 25, 2015: Broda Technologies entered a license agreement with Redwood Pharma AB of Sweden for its novel IntelliGel; drug delivery system - A smart supramolecular hydrogel drug delivery system for the development of new ophthalmic therapies.

October 21, 2014: Broda Receives US Patent for Thermal-Reversible Hydrogel Drug Delivery System - Advanced Supramolecular Drug Delivery Technology Platform for Water Insoluble or Sparely Soluble Drugs.

October 02, 2012: Dr. Shao Xiang Lu, President of Broda Technologies Co., Ltd., has been invited to talk at Innovation Prize Finalists which will be held as a part of Innovation Days 2012 Conference in Paris, France on October 2, 2012. The topic of his presentation is "IntelliGel™  ̶̶ ̶̶ ̶̶  Supramolecular Smart Hydrogel Drug Delivery System".

June 18, 2012: Broda IntelliGel™ project has been selected in the 15 finalists by The Universal Biotech Innovation Prize 2012. The Universal Biotech Innovation Prize is open to Small and Medium Enterprises from Europe and China and to academics researchers on: preventive and curative therapies, medical devices, and technology tools.

March 22, 2012: Broda Anti-fungal IntelliGel™ had received "Clinical Protocol Approval" and "Principle Investigator Approval" from US IRB.

July 26, 2011: Broda company's profile was published by Lux Research on innovative companies active in emerging technologies. For details, please visit: https://portal.luxresearchinc.com/research/profile_excerpt/Broda_Technologies.